In thyroid cancer cells, over expression of the IGF2BP3/IGF2 axis correlates with enhanced activation of the Akt and ERK pathways, increased cell proliferation and sensitivity to the dual inhibitor OSI-906 [82]. This evidence concerns the gene IGF2 and thyroid gland carcinoma.